Simple Summary The circadian cycle is a natural cycle of the body repeated every 24 h,
based on a day and night rhythm, and it affects many body processes. The present article …

Oncolytic viruses (OVs) are emerging cancer immunotherapy. Despite notable successes in
the treatment of some tumors, OV therapy for central nervous system cancers has failed to …

Anti-PD1 immune checkpoint blockade (ICB) has shown promising results for treating
several aggressive cancers, enhancing patient survival rates. The variability in clinical …

Drug-induced resistance, or tolerance, is an emerging yet poorly understood failure of
anticancer therapy. The interplay between drug-tolerant cancer cells and innate immunity …

Immune checkpoint inhibitors, such as anti-PD-1 antibodies, represent a significant
advancement in cancer immunotherapy, but their efficacy varies notably between …

Cancer is a complex disease that continues to affect millions of people around the world
every year. With ever-improving science and technology, several forms of treatment have …